An International, Multicenter, Prospective Registry on Post-traumatic Long Bones Defects
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- AO Innovation Translation Center
- Study ID
- NCT04112992
- Status
- Recruiting
Conditions
- Bone Loss
- Limb Fracture
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Any treatment that is used for a defect of any long bone — PROCEDUREAny treatment that is used for a defect of any long bone. All treatments are based on individual clinician's judgement and the patient characteristics. The registry does not dictate any specific treatment.
Study Details
Long bone defect (LBD) is defined as a focalized loss of bone tissue in any long bone of the upper or lower extremity. Long bone defects are a complex problem, that may arise as a complication of many different pathologies, such as trauma, tumors or infection. Whereas post-traumatic defects are the largest group. Reports estimate that there are almost 4 million bone grafting procedures worldwide per year. However, limb reconstruction in the context of a bony defect is challenging and up to date there is little evidence and treatment recommendations. In a multi-national approach, the aim of this project is to set up an international, multicenter registry to gather information and details on prevalence or incidence, current treatments, complications and outcome.
Key Dates
- Start date
- Jul 3, 2024
- Status verified
- Aug 2025
- Primary completion
- May 31, 2028
- Completion
- Mar 30, 2029
Study Design
- Enrollment
- 600 participants (estimated)
Primary Outcome Measure
Baseline characteristics [ Time Frame: Pre-operative ]
Central Contacts
- Marco Minoia+41 79 612 09 67
- Joelle Kägi+41 79 549 32 83
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cedar Sinai | Los Angeles | California | 90048 | Geoffrey Marecek, MD |
| Sinai Hospital of Baltimore | Baltimore | Maryland | 21215 | Janet Conway |
Find similar trials in Los Angeles, CA
Related Studies
- Release Kinetics of rhBMP-2 Using E-PRF as an Autologous Carrier: An In Vitro AnalysisNot Yet Recruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric SurgeryPHASE3 · Recruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina
- Ridge Augmentation Using Allograft Particles Hydrated With or Without Recombinant Human Platelet-Derived Growth FactorRecruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Skeletal Effects of Type 1 Diabetes on Low-Trauma Fracture RiskRecruiting · Creighton University · Omaha, Nebraska